| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.87 | 0.002 | 0.87 | Cytidine deaminase inhibitor | 0.87 0.002 DBMET03186 | ||
| 0.824 | 0.003 | 0.824 | DNA synthesis inhibitor | 0.824 0.003 DBMET03186 | ||
| 0.47 | 0.003 | 0.47 | UDP-glucose 4-epimerase inhibitor | 0.47 0.003 DBMET03186 | ||
| 0.438 | 0.015 | 0.438 | RNA-directed DNA polymerase inhibitor | 0.438 0.015 DBMET03186 | ||
| 0.429 | 0.023 | 0.429 | DNA damaging | 0.429 0.023 DBMET03186 | ||
| 0.446 | 0.058 | 0.446 | Antibacterial | 0.446 0.058 DBMET03186 | ||
| 0.377 | 0.009 | 0.377 | Alkylator | 0.377 0.009 DBMET03186 | ||
| 0.332 | 0.013 | 0.332 | Alpha-N-acetylglucosaminidase inhibitor | 0.332 0.013 DBMET03186 | ||
| 0.38 | 0.062 | 0.38 | Vasodilator, peripheral | 0.38 0.062 DBMET03186 | ||
| 0.285 | 0.002 | 0.285 | Thymidine kinase inhibitor | 0.285 0.002 DBMET03186 | ||
| 0.263 | 0.006 | 0.263 | Antimetabolite | 0.263 0.006 DBMET03186 | ||
| 0.276 | 0.035 | 0.276 | Peptidyltransferase inhibitor | 0.276 0.035 DBMET03186 | ||
| 0.305 | 0.07 | 0.305 | Interleukin 2 agonist | 0.305 0.07 DBMET03186 | ||
| 0.263 | 0.037 | 0.263 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.263 0.037 DBMET03186 | ||
| 0.358 | 0.135 | 0.358 | Apoptosis agonist | 0.358 0.135 DBMET03186 | ||
| 0.358 | 0.139 | 0.358 | Caspase 9 stimulant | 0.358 0.139 DBMET03186 | ||
| 0.228 | 0.021 | 0.228 | DNA polymerase I inhibitor | 0.228 0.021 DBMET03186 | ||
| 0.209 | 0.008 | 0.209 | DNA repair enzyme inhibitor | 0.209 0.008 DBMET03186 | ||
| 0.214 | 0.014 | 0.214 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.214 0.014 DBMET03186 | ||
| 0.203 | 0.01 | 0.203 | NADH dehydrogenase inhibitor | 0.203 0.01 DBMET03186 | ||
| 0.193 | 0.012 | 0.193 | Phosphofructokinase-1 inhibitor | 0.193 0.012 DBMET03186 | ||
| 0.181 | 0.007 | 0.181 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.181 0.007 DBMET03186 | ||
| 0.151 | 0.012 | 0.151 | Ribonucleotide reductase inhibitor | 0.151 0.012 DBMET03186 | ||
| 0.146 | 0.012 | 0.146 | Ribonucleoside-diphosphate reductase inhibitor | 0.146 0.012 DBMET03186 | ||
| 0.136 | 0.005 | 0.136 | Phosphoglycerate kinase inhibitor | 0.136 0.005 DBMET03186 | ||
| 0.135 | 0.005 | 0.135 | Glucosylceramidase inhibitor | 0.135 0.005 DBMET03186 | ||
| 0.133 | 0.013 | 0.133 | Carbamoyl phosphate synthetase inhibitor | 0.133 0.013 DBMET03186 | ||
| 0.132 | 0.035 | 0.132 | Adenylate kinase inhibitor | 0.132 0.035 DBMET03186 | ||
| 0.096 | 0.007 | 0.096 | Alpha-mannosidase inhibitor | 0.096 0.007 DBMET03186 | ||
| 0.151 | 0.071 | 0.151 | NOS3 expression enhancer | 0.151 0.071 DBMET03186 | ||
| 0.099 | 0.019 | 0.099 | Argininosuccinate synthase inhibitor | 0.099 0.019 DBMET03186 | ||
| 0.085 | 0.008 | 0.085 | Mannosidase inhibitor | 0.085 0.008 DBMET03186 | ||
| 0.066 | 0.005 | 0.066 | Uridine phosphorylase inhibitor | 0.066 0.005 DBMET03186 | ||
| 0.066 | 0.008 | 0.066 | HCV NS5B polymerase inhibitor | 0.066 0.008 DBMET03186 | ||
| 0.065 | 0.008 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 DBMET03186 | ||
| 0.122 | 0.066 | 0.122 | Adenylate cyclase inhibitor | 0.122 0.066 DBMET03186 | ||
| 0.067 | 0.015 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET03186 | ||
| 0.06 | 0.012 | 0.06 | Nicotinic receptor beta4 subunit antagonist | 0.06 0.012 DBMET03186 | ||
| 0.057 | 0.01 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET03186 | ||
| 0.179 | 0.134 | 0.179 | Immunostimulant | 0.179 0.134 DBMET03186 | ||
| 0.047 | 0.003 | 0.047 | 1,3-Beta-glucan synthase inhibitor | 0.047 0.003 DBMET03186 | ||
| 0.042 | 0.004 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.042 0.004 DBMET03186 | ||
| 0.042 | 0.006 | 0.042 | Thymidine phosphorylase inhibitor | 0.042 0.006 DBMET03186 | ||
| 0.058 | 0.026 | 0.058 | Phosphorylase inhibitor | 0.058 0.026 DBMET03186 | ||
| 0.066 | 0.035 | 0.066 | Biliverdin reductase inhibitor | 0.066 0.035 DBMET03186 | ||
| 0.037 | 0.009 | 0.037 | Adenosine A1 receptor agonist | 0.037 0.009 DBMET03186 | ||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.03 0.004 DBMET03186 | ||
| 0.084 | 0.061 | 0.084 | Transcription factor NF kappa B stimulant | 0.084 0.061 DBMET03186 | ||
| 0.04 | 0.017 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 DBMET03186 | ||
| 0.128 | 0.106 | 0.128 | Adenylate cyclase stimulant | 0.128 0.106 DBMET03186 | ||
| 0.05 | 0.028 | 0.05 | Thymidylate synthase inhibitor | 0.05 0.028 DBMET03186 | ||
| 0.057 | 0.035 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET03186 | ||
| 0.072 | 0.054 | 0.072 | Glutamate dehydrogenase inhibitor | 0.072 0.054 DBMET03186 | ||
| 0.054 | 0.036 | 0.054 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET03186 | ||
| 0.048 | 0.032 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.032 DBMET03186 | ||
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET03186 | ||
| 0.035 | 0.021 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET03186 | ||
| 0.052 | 0.038 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 DBMET03186 | ||
| 0.139 | 0.126 | 0.139 | Anesthetic general | 0.139 0.126 DBMET03186 | ||
| 0.083 | 0.07 | 0.083 | Triose-phosphate isomerase inhibitor | 0.083 0.07 DBMET03186 | ||
| 0.03 | 0.018 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DBMET03186 | ||
| 0.165 | 0.153 | 0.165 | Interleukin agonist | 0.165 0.153 DBMET03186 | ||
| 0.052 | 0.041 | 0.052 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.041 DBMET03186 | ||
| 0.156 | 0.148 | 0.156 | Vasodilator | 0.156 0.148 DBMET03186 | ||
| 0.018 | 0.01 | 0.018 | Adenosine A3 receptor agonist | 0.018 0.01 DBMET03186 | ||
| 0.027 | 0.019 | 0.027 | Purinergic P2X agonist | 0.027 0.019 DBMET03186 | ||
| 0.091 | 0.084 | 0.091 | AMP-activated protein kinase stimulant | 0.091 0.084 DBMET03186 | ||
| 0.025 | 0.018 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.018 DBMET03186 | ||
| 0.016 | 0.01 | 0.016 | Purinergic P2 agonist | 0.016 0.01 DBMET03186 | ||
| 0.016 | 0.01 | 0.016 | Purinergic receptor agonist | 0.016 0.01 DBMET03186 | ||
| 0.093 | 0.088 | 0.093 | Mucolytic | 0.093 0.088 DBMET03186 | ||
| 0.014 | 0.01 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.01 DBMET03186 | ||
| 0.023 | 0.018 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET03186 | ||
| 0.015 | 0.01 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 DBMET03186 | ||
| 0.133 | 0.13 | 0.133 | Hepatoprotectant | 0.133 0.13 DBMET03186 | ||
| 0.01 | 0.007 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.007 DBMET03186 | ||
| 0.014 | 0.011 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.011 DBMET03186 | ||
| 0.012 | 0.009 | 0.012 | Purinergic P2Y agonist | 0.012 0.009 DBMET03186 | ||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 DBMET03186 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |